TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers report that the enzyme-producing gene Pla2g2f helped preserve memory and limit several brain-aging changes in mice when its activity was increased. The study also found reduced lipid-droplet buildup in human microglia, but whether safely boosting the enzyme could benefit people remains unknown.
Researchers report that increasing activity of Pla2g2f, a gene that produces a secreted phospholipase enzyme, protected aging mice against memory impairment and several brain changes associated with aging. The study, published in Nature Neuroscience, also found that increasing the gene’s activity reduced lipid buildup in human microglia in laboratory experiments, but it does not establish a treatment for people.
Lead author Cinzia Vicidomini and senior author Amar Sahay, of Mass General Brigham, the Harvard Stem Cell Institute and the Broad Institute, led the research. The team looked for genes activated in response to synapse loss in the hippocampus, a brain region involved in memory, in mice. They identified Pla2g2f, whose role in the brain had not previously been established in the study’s account.
The researchers found that Pla2g2f levels rose in the hippocampus with age and during brain inflammation. They also reported higher levels in older adults with signs of Alzheimer’s pathology who remained cognitively resilient. That human observation is an association; it does not show that the enzyme caused resilience in those people.
In aging mice, reducing Pla2g2f worsened several measured features, including synapse loss, inflammation, disrupted lipid metabolism and memory impairment. Increasing its activity protected against many of those changes and helped preserve memory. Raising levels in middle-aged mice before substantial cognitive decline also changed the course of age-related memory loss, the authors reported. In experiments involving human microglia, the team found less accumulation of lipid droplets and cholesterol esters when Pla2g2f activity was increased.
A Possible Route to Preserve Memory
The findings point to a possible biological mechanism that could help explain why some brains withstand age-related changes better than others. Pla2g2f was linked to several processes at once, including synapse maintenance, inflammation and lipid handling, rather than memory alone. That breadth makes the enzyme a potential focus for future research into cognitive resilience.
The results matter because aging is a major risk factor for Alzheimer’s disease and cognitive decline, but the experiments do not show that raising Pla2g2f can prevent or delay either condition in people. The work establishes a candidate for further study, not a proven therapy. Any future treatment would need evidence of safety and benefit in human studies.
brain enzyme supplements for cognitive health
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How Researchers Found Pla2g2f
The study addressed the relationship between aging, synapse loss and changes in microglia, immune cells that help support the brain and clear waste. The researchers focused on the hippocampus because loss of its synapses is associated with age-related memory decline. Their approach was to identify genes that respond to synapse loss, then alter the candidate gene’s levels in mice to examine its effects.
The authors describe lipid-droplet buildup in microglia as one feature linked to impaired support for neurons and synapses. Their experiments extended the investigation to human microglia, where increasing Pla2g2f activity reduced lipid droplets and cholesterol esters. The paper, An aging-sensitive secreted phospholipase confers neuroprotection and cognitive resilience, was published in Nature Neuroscience in 2026 (DOI: 10.1038/s41593-026-02465-z).
“We sought to identify the protective factors that contribute to cognitive resilience during aging.”
— Cinzia Vicidomini and Amar Sahay, study authors, as quoted by News-Medical
As an affiliate, we earn on qualifying purchases.
Human Benefits Remain Unproven
The evidence does not establish that increasing Pla2g2f will preserve memory or prevent mild cognitive impairment or Alzheimer’s disease in people. The study reports experiments in mice and human microglia, along with an observation involving older adults with Alzheimer’s pathology who remained cognitively resilient. These are different forms of evidence and do not demonstrate a treatment effect in patients.
The supplied report does not provide the number of human samples, the size of the effects, or details on how an intervention could raise the enzyme safely in the brain. Potential risks, appropriate timing and the duration of any benefit also remain unresolved. The researchers say further work is required before clinical use can be assessed.
nootropic supplements for memory preservation
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Testing Safe Ways to Raise Activity
The research team says it is exploring ways to increase Pla2g2f levels safely in the aging brain and in Alzheimer’s disease. The next steps will need to determine how such an approach could be delivered, whether it produces durable effects and whether those effects are safe. The source report gives no timeline for these studies or for any human trials.
For now, the main development is a preclinical finding that identifies Pla2g2f as a possible contributor to cognitive resilience. Further research will be needed to establish whether the results can be reproduced and translated into a strategy that benefits patients.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is Pla2g2f?
Pla2g2f is a gene that produces a secreted phospholipase enzyme. The study investigated its role in brain aging and reported protective effects when its activity was increased in experiments.
Did the enzyme prevent memory decline in people?
No. The reported memory findings came from aging mice. The human component described in the source included observations in older adults and experiments with human microglia, not a clinical test showing improved memory.
What changed when researchers increased Pla2g2f in mice?
The authors reported protection against several aging-related changes, including synapse loss, inflammation, lipid disruption and memory impairment. Increasing activity in middle-aged mice also altered the trajectory of age-related memory loss, according to the study.
Could this lead to an Alzheimer’s treatment?
It is a possible research direction, not an available treatment. The authors say more studies are needed to determine whether Pla2g2f can be increased safely and whether doing so would help patients.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
